~~<i id='DC76D4213B'><strike id='DC76D4213B'><tt id='DC76D4213B'><pre id='DC76D4213B'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

hotspot

author：Wikipedia 2025-09-27 12:34:48 - browse：41176

translucent 3D DNA helix with blue and purple background — Adobe

Verve Therapeutics said Monday that it had received clearance from the Food and Drug Administration to conduct a clinical trial in the U.S. of its experimental, gene-editing treatment for a common form of heart disease.

The FDA’s action removes a clinical hold on Verve’s CRISPR-based therapy, called VERVE-101, that was placed on it last November. Verve now intends to recruit participants from U.S. sites into a Phase 1 study that’s been underway since last year in New Zealand and the United Kingdom.

“We’re thrilled to get this clearance for VERVE-101,” said Verve CEO Sek Kathiresan. “Our study is called HEART-1 and our plan now is to activate U.S. sites.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： HPV cancer vaccine study demonstrates efficacy

leisure time

entertainment

focus

hotspot

focus

knowledge

Afteradrawn-outlobbyingfight,ARPA-Hchoseitsheadquarters:ahubandspokesmodel,withthreecentrallocations

WSS

Removing probiotics from the NICU could threaten preemies' health

The Sacklers, horror, and ‘The Fall of the House of Usher’

Abortion clinic in Cancun will cater to Americans

Sudafed saga points to U.S. issues with evaluating older drugs

Senator probes 340B programs at Cleveland Clinic, Bon Secours

Removing probiotics from the NICU could threaten preemies' health

focus

hotspot

leisure time

Apple is now the first public company to be valued at $3 trillion

Sudafed saga points to U.S. issues with evaluating older drugs

United colonoscopy coverage change 'may cost lives,' doctors say

How the Dana

Alkermes shareholders re

Why do women spend more than men on medical expenses?

Continuity nursing helped my family in our darkest PICU moments

Sudafed saga points to U.S. issues with evaluating older drugs

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Victims of gun violence feel impacts long after bullet wound

entertainment

The new shift in health care is toward less care

Victims of gun violence feel impacts long after bullet wound

Medicaid, Medicare dual

Shingles, which affected Dianne Feinstein, is on the rise

Biogen shutters digital health group, ends Apple study, in cost cutting move

Would Medicare drug price negotiations stall in a shutdown?

focus

hotspot

focus

knowledge